Osteoporotic Fracture Models

Current Osteoporosis Reports

Volumn 13, Issue 1, 2015, Pages 9-15

  Simpson, A Hamish ^a   Murray, Iain R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Animal model; Fracture healing; Osteoporosis

Indexed keywords

BONE IMPLANT; BONE MASS; BONE REMODELING; BONE STRENGTH; CORTICAL BONE; FRACTURE HEALING; FRAGILITY FRACTURE; GENETIC RECOMBINATION; HUMAN; MOUSE MODEL; MURINE MODEL; NONHUMAN; OSTEOPENIA; OVARIECTOMY-INDUCED OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RODENT MODEL; SECONDARY OSTEOPOROSIS; SENILE OSTEOPOROSIS; TENSILE STRENGTH; TRABECULAR BONE; TRANSGENIC MOUSE; ANIMAL; CLASSIFICATION; COMPLICATION; DISEASE MODEL; OSTEOPOROSIS; PATHOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE, TRANSGENIC; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES;

EID: 84925517604     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-014-0246-8     Document Type: Review

References (43)

1. Davidson MK, Lindsey JR, Davis JK. Requirements and selection of an animal model. Isr J Med Sci. 1987;23(6):551–5.
2. Simon LS. Osteoporosis. Rheum Dis Clin North Am. 2007;33(1):149–76. doi:10.1016/j.rdc.2006.12.005.
3. Gehron Robey P. The biochemistry of bone. Endocrinol Metab Clin North Am. 1989;18(4):858–902.
4. Riggs BL, Melton 3rd LJ. Involutional osteoporosis. N Engl J Med. 1986;314(26):1676–86. doi:10.1056/nejm198606263142605.
5. Prior JC, Vigna YM, Schechter MT, Burgess AE. Spinal bone loss and ovulatory disturbances. N Engl J Med. 1990;323(18):1221–7. doi:10.1056/nejm199011013231801.
6. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332(5):305–11. doi:10.1056/nejm199502023320506.
7. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000;15(8):1526–36. doi:10.1359/jbmr.2000.15.8.1526.
8. Whyte MP, Bergfeld MA, Murphy WA, Avioli LV, Teitelbaum SL. Postmenopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients. Am J Med. 1982;72(2):193–202.
9. Riggs BL, Melton 3rd LJ. The prevention and treatment of osteoporosis. N Engl J Med. 1992;327(9):620–7. doi:10.1056/nejm199208273270908.
10. Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest. 1983;72(4):1396–409. doi:10.1172/jci111096.
11. Egermann M, Goldhahn J, Schneider E. Animal models for fracture treatment in osteoporosis. Osteoporos Int. 2005;16 Suppl 2:S129–38. doi:10.1007/s00198-005-1859-7.
12. Jacenko O, Olsen BR. Transgenic mouse models in studies of skeletal disorders. J Rheumatol Suppl. 1995;43:39–41.
13. Houdebine LM. Transgenic animal models in biomedical research. Methods Mol Biol. 2007;360:163–202. doi:10.1385/1-59745-165-7:163.
14. Holstein JH, Garcia P, Histing T, Kristen A, Scheuer C, Menger MD, et al. Advances in the establishment of defined mouse models for the study of fracture healing and bone regeneration. J Orthop Trauma. 2009;23(5 Suppl):S31–8. doi:10.1097/BOT.0b013e31819f27e5.
15. Mills LA, Simpson AH. In vivo models of bone repair. J Bone Joint Surg Br. 2012;94(7):865–74. doi:10.1302/0301-620x.94b7.27370. Up to date review outlining clinical scenarios of fracture healing and the available animal models that best reflect them.
16. Nunamaker DM. Experimental models of fracture repair. Clin Orthop Relat Res. 1998;355 Suppl:S56–65.
17. Okamoto Y, Takahashi K, Toriyama K, Takeda N, Kitagawa K, Hosokawa M, et al. Femoral peak bone mass and osteoclast number in an animal model of age-related spontaneous osteopenia. Anat Rec. 1995;242(1):21–8. doi:10.1002/ar.1092420104.
18. Silva MJ, Brodt MD, Ettner SL. Long bones from the senescence accelerated mouse SAMP6 have increased size but reduced whole-bone strength and resistance to fracture. J Bone Miner Res. 2002;17(9):1597–603. doi:10.1359/jbmr.2002.17.9.1597.
19. Kajkenova O, Lecka-Czernik B, Gubrij I, Hauser SP, Takahashi K, Parfitt AM, et al. Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J Bone Miner Res. 1997;12(11):1772–9. doi:10.1359/jbmr.1997.12.11.1772.
20. Syed FA, Hoey KA. Integrative physiology of the aging bone: insights from animal and cellular models. Ann N Y Acad Sci. 2010;1211:95–106. doi:10.1111/j.1749-6632.2010.05813.x.
21. Histing T, Stenger D, Kuntz S, Scheuer C, Tami A, Garcia P, et al. Increased osteoblast and osteoclast activity in female senescence-accelerated, osteoporotic SAMP6 mice during fracture healing. J Surg Res. 2012;175(2):271–7. doi:10.1016/j.jss.2011.03.052.
22. Histing T, Kuntz S, Stenger D, Scheuer C, Garcia P, Holstein JH, et al. Delayed fracture healing in aged senescence-accelerated P6 mice. J Invest Surg. 2013;26(1):30–5. doi:10.3109/08941939.2012.687435. Study of closed femoral fracture healing in senescence accelerated osteoporotic mice (SAMP6). Fracture healing was delayed in osteoporotic mice aged 10 months.
23. Egermann M, Heil P, Tami A, Ito K, Janicki P, Von Rechenberg B, et al. Influence of defective bone marrow osteogenesis on fracture repair in an experimental model of senile osteoporosis. J Orthop Res. 2010;28(6):798–804. doi:10.1002/jor.21041.
24. Ding WG, Zhang ZM, Zhang YH, Jiang SD, Jiang LS, Dai LY. Changes of substance P during fracture healing in ovariectomized mice. Regul Pept. 2010;159(1–3):28–34. doi:10.1016/j.regpep.2009.11.004.
25. Li M, Healy DR, Li Y, Simmons HA, Crawford DT, Ke HZ, et al. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Bone. 2005;37(1):46–54. doi:10.1016/j.bone.2005.03.016.
26. Kubo T, Shiga T, Hashimoto J, Yoshioka M, Honjo H, Urabe M, et al. Osteoporosis influences the late period of fracture healing in a rat model prepared by ovariectomy and low calcium diet. J Steroid Biochem Mol Biol. 1999;68(5–6):197–202.
27. Perkins SL, Gibbons R, Kling S, Kahn AJ. Age-related bone loss in mice is associated with an increased osteoclast progenitor pool. Bone. 1994;15(1):65–72.
28. Cao J, Venton L, Sakata T, Halloran BP. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res. 2003;18(2):270–7. doi:10.1359/jbmr.2003.18.2.270.
29. Ferguson VL, Ayers RA, Bateman TA, Simske SJ. Bone development and age-related bone loss in male C57BL/6J mice. Bone. 2003;33(3):387–98.
30. Bergman RJ, Gazit D, Kahn AJ, Gruber H, McDougall S, Hahn TJ. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res. 1996;11(5):568–77. doi:10.1002/jbmr.5650110504.
31. Meyer Jr RA, Desai BR, Heiner DE, Fiechtl J, Porter S, Meyer MH. Young, adult, and old rats have similar changes in mRNA expression of many skeletal genes after fracture despite delayed healing with age. J Orthop Res. 2006;24(10):1933–44. doi:10.1002/jor.20124.
32. D’Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res. 1999;14(7):1115–22. doi:10.1359/jbmr.1999.14.7.1115.
33. Tabensky A, Duan Y, Edmonds J, Seeman E. The contribution of reduced peak accrual of bone and age-related bone loss to osteoporosis at the spine and hip: insights from the daughters of women with vertebral or hip fractures. J Bone Miner Res. 2001;16(6):1101–7. doi:10.1359/jbmr.2001.16.6.1101.
34. Melton 3rd LJ, Beck TJ, Amin S, Khosla S, Achenbach SJ, Oberg AL, et al. Contributions of bone density and structure to fracture risk assessment in men and women. Osteoporos Int. 2005;16(5):460–7. doi:10.1007/s00198-004-1820-1.
35. Watanabe K, Hishiya A. Mouse models of senile osteoporosis. Mol Aspects Med. 2005;26(3):221–31. doi:10.1016/j.mam.2005.01.006.
36. Oheim R, Beil FT, Kohne T, Wehner T, Barvencik F, Ignatius A, et al. Sheep model for osteoporosis: sustainability and biomechanical relevance of low turnover osteoporosis induced by hypothalamic-pituitary disconnection. J Orthop Res. 2013;31(7):1067–74. doi:10.1002/jor.22327. Outlines a novel large animal model of primary type 2 (senile) osteoporosis. Hypothalamic-pituitary dissociation in sheep resulted in a low-turnover form of osteoporosis.
37. Horton WA. Skeletal development: insights from targeting the mouse genome. Lancet. 2003;362(9383):560–9. doi:10.1016/s0140-6736(03)14119-0.
38. Rosen CJ, Beamer WG, Donahue LR. Defining the genetics of osteoporosis: using the mouse to understand man. Osteoporos Int. 2001;12(10):803–10. doi:10.1007/s001980170030.
39. Abbott A. Laboratory animals: the Renaissance rat. Nature. 2004;428(6982):464–6. doi:10.1038/428464a.
40. A M. Fracture healing in osteopenic bone and the influence of simvastatin. Edinburgh: The University of Edinburgh; 2006.
41. Stuermer EK, Sehmisch S, Rack T, Wenda E, Seidlova-Wuttke D, Tezval M, et al. Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat. Langenbecks Arch Surg. 2010;395(2):163–72. doi:10.1007/s00423-008-0436-x.
42. Hiltunen A, Vuorio E, Aro HT. A standardized experimental fracture in the mouse tibia. J Orthop Res. 1993;11(2):305–12. doi:10.1002/jor.1100110219.
43. Manigrasso MB, O’Connor JP. Characterization of a closed femur fracture model in mice. J Orthop Trauma. 2004;18(10):687–95.